In February 2026, FDA finalized its Computer Software Assurance (CSA) guidance, reinforcing a risk-based, evidence-driven approach to computer system validation, explicitly bringing AI/ML systems into scope, and recognizing system logs, audit trails, and digital records as legitimate validation evidence rather than relying solely on manually executed test scripts. That shift bears directly on how IQ/OQ protocols get written and what counts as acceptable supporting evidence behind them.
Here’s the part that actually matters to whoever owns the budget for this: the expensive part of validation was never the requirement. It’s the internal lift.
The real cost isn’t compliance. It’s the six months before it.
Every organization that’s been through a validation project knows the shape of it: stand up a project team, pull people off their regular jobs, learn whatever tooling you’ve decided to use this time, then spend months manually drafting IQ/OQ test scripts and walking a gap assessment section by section. By the time the package is done, the system it validated may already have changed.
That internal build-out, the staffing, the tooling, the ramp-up, is the cost that never shows up in a scoping conversation but always shows up in the timeline. Validation as a Service exists specifically to remove it.
What Validation as a Service actually is
It’s a consulting engagement, not a software purchase. CIMCON’s team runs the project start to finish, over a matter of weeks, and the client receives the finished deliverable: completed IQ/OQ protocols and a gap assessment, ready to file. Nothing to implement. Nothing to learn. No new platform for your team to stand up and maintain after we leave.
The ROI case is the whole point: validated systems, on a known timeline, without the upfront technical lift that normally has to happen before a single test script gets written.
What’s actually inside the deliverable
IQ/OQ test cases aren’t generated in a vacuum. Each one is grounded in, and traceable back to, the source requirements: your URS, your functional specifications, the actual documents that define what the system is supposed to do. Alongside the protocols, the gap assessment identifies open items against the applicable requirements and lays out what’s needed to close them.
Every piece of it, protocols and assessment alike, is reviewed and signed off by CIMCON’s team before it reaches you. AI accelerates how fast CIMCON’s team can draft and cross-reference across a large requirement set; it doesn’t replace the human judgment that decides whether a test case is actually right. What lands in your hands is a reviewed deliverable, not raw model output.
Why the timing matters right now
FDA’s final CSA guidance gives clients, and their auditors, more confidence that an AI-accelerated, evidence-based engagement like this reflects where FDA’s own expectations have actually moved: risk-based over prescriptive, digital evidence over paper assembled after the fact. That’s not a loophole being exploited ahead of the regulation catching up. It’s the regulation explicitly making room for this approach.
The takeaway
If the thing standing between you and a validated system isn’t the requirement itself but the six months of internal project standup it normally takes to get there, that’s exactly the gap Validation as a Service is built to close. You don’t staff it. You don’t implement anything. You get the protocols and the assessment, reviewed and ready.
| Want to see what a Validation as a Service engagement would look like for your systems? Contact CIMCON to talk through scope and timeline. |
